Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat.
The effect of rat amylin on gastric emptying and intestinal transit in the rat was examined. Amylin administered intracerebroventricularly (1, 2, 2.5 or 4 micrograms/rat) produced the maximal decrease in gastric emptying and intestinal transit at the dose of 2.5 micrograms/rat. Higher doses produced a lower effect. Peripheral administration (25, 50 or 100 micrograms/kg) produced dose-dependent effects. Pre-treatment with neostigmine blocked the effect of amylin when it was centrally injected, while the effect of amylin given peripherally was partially reduced. Pre-treatment with domperidone decreased the inhibitory effect of peripherally injected amylin, but no effect was observed when the peptide was centrally injected.
Clementi
G
G
Institute of Pharmacology, University of Catania, School of Medicine, Italy.
Caruso
A
A
Cutuli
V M
VM
de Bernardis
E
E
Prato
A
A
Amico-Roxas
M
M
D000682:Amyloid / Q000008:administration & dosage* / Q000494:pharmacology*; D000818:Animals; D005746:Gastric Emptying / Q000187:drug effects*; D005772:Gastrointestinal Transit / Q000187:drug effects*; D007276:Injections, Intraventricular; D007279:Injections, Subcutaneous; D058228:Islet Amyloid Polypeptide; D008297:Male; D009388:Neostigmine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
D000682:Amyloid; D058228:Islet Amyloid Polypeptide; D009388:Neostigmine